New incident report
Incident Report Number: 2020-1492
Registrant Reference Number: 2020-US-002267
Registrant Name (Full Legal Name no abbreviations): Wellmark International
Address: 100 Stone Road West, Suite 111
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G5L3
Domestic Animal
Country: UNITED STATES
Prov / State: GEORGIA
PMRA Registration No. 31446 PMRA Submission No. EPA Registration No. 2596-83-89459
Product Name: Zodiac Breakaway Flea and Tick Collar for Cats
Other (specify)
CollarYes
Other Units: collar
Site: Animal / Usage sur un animal domestique
No
Animal's Owner
Cat / Chat
Domestic Shorthair Cat
1
Male
5
4.99
kg
Skin
>24 hrs <=3 days / >24 h <=3 jours
>24 hrs <=3 days / >24 h <=3 jours
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 7-Feb-2020 the animal owner applied the product to their cat. Excessive collar material was not trimmed off. This was the first time the product had been used. The animal owner woke up on 10-Feb-2020 and found the cat dead. The cat has been buried. No further information is available.
Death
Assessment: This product is considered to have a wide margin of safety in cats. The collar was not applied according to the label as the extra amount of collar material was not removed. If the extra collar was chewed on or ingested, GI upset such as vomiting or diarrhea could have occurred. Acute onset of death is not expected and other causes such as cardiac disease, respiratory disease, trauma, and toxin exposure should be considered. Necropsy may have provided additional information but was not sought by the animal owner. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.